US 12090142
Combination therapy for the treatment of cancer
granted A61KA61K2039/505A61K31/4188
Quick answer
US patent 12090142 (Combination therapy for the treatment of cancer) held by The Board of Regents of the University of Texas System expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Sep 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K2039/505, A61K31/4188, A61K39/3955, A61K39/39558